We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lennar Class A
LEN
$20.4B
| $36.9M | 0.08% |
511,041
+113,899
| +29% | +$8.85M |
|
|
K
277
DELISTED
Kellanova
K
| $36.7M | 0.08% |
560,735
+305,304
| +120% | +$21M |
|
278
Darling Ingredients
DAR
$9.93B
| $36.4M | 0.08% |
550,922
-250,101
| -31% | -$17.4M |
|
279
Repligen
RGEN
$7.44B
| $36.4M | 0.08% |
194,315
-178,562
| -48% | -$37.7M |
|
|
CONX
280
DELISTED
CONX Corp. Class A Common Stock
CONX
| $36.2M | 0.08% |
3,618,769
| – | – |
|
|
PR
281
Permian Resources
PR
$17.9B
| $36.1M | 0.08% |
5,312,382
+1,428,349
| +37% | +$9.87M |
|
282
HCA Healthcare
HCA
$84.8B
| $36.1M | 0.08% |
196,191
+147,352
| +302% | +$29.4M |
|
283
Nutanix
NTNX
$14.9B
| $36M | 0.08% |
1,727,700
+1,027,866
| +147% | +$18.8M |
|
|
HERA
284
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $35.8M | 0.08% |
3,604,283
+152,431
| +4% | +$1.5M |
|
285
argenx
ARGX
$57.4B
| $35.7M | 0.08% |
+101,232
| New | +$37.5M |
|
286
Elastic
ESTC
$6.1B
| $35.7M | 0.08% |
497,782
-88,625
| -15% | -$7.05M |
|
287
Altria Group
MO
$122B
| $35.7M | 0.08% |
884,110
-2,317,201
| -72% | -$101M |
|
288
e.l.f. Beauty
ELF
$4.56B
| $35.5M | 0.08% |
942,438
+389,163
| +70% | +$14M |
|
289
Carlyle Group
CG
$16.3B
| $35M | 0.08% |
1,354,918
+808,153
| +148% | +$26.6M |
|
290
Lantheus
LNTH
$6.82B
| $34.8M | 0.08% |
495,123
+381,320
| +335% | +$28.9M |
|
291
Host Hotels & Resorts
HST
$16.8B
| $34.8M | 0.08% |
2,192,333
+1,574,198
| +255% | +$27.4M |
|
292
Cenovus Energy
CVE
$54.6B
| $34.7M | 0.08% |
2,259,786
+1,482,670
| +191% | +$26.3M |
|
|
LGV
293
DELISTED
Longview Acquisition Corp. II
LGV
| $34.7M | 0.08% |
3,532,408
| – | – |
|
294
Armstrong World Industries
AWI
$6.86B
| $34.7M | 0.08% |
437,534
-270,450
| -38% | -$22.9M |
|
|
SCHW
295
Charles Schwab
SCHW
$177B
| $34.6M | 0.08% |
481,584
+445,923
| +1,250% | +$31M |
|
296
CALL
Alibaba
BABA
$269B
| $34.6M | 0.08% |
432,500
+10,600
| +3% | +$1.01M |
|
297
Alignment Healthcare
ALHC
$4.02B
| $34.1M | 0.07% |
+2,882,359
| New | +$42.1M |
|
298
Norwegian Cruise Line
NCLH
$8.89B
| $34M | 0.07% |
2,989,651
-63,201
| -2% | -$832K |
|
299
CALL
Tesla
TSLA
$1.24T
| $33.7M | 0.07% |
127,000
+112,000
| +747% | +$31.3M |
|
300
Phillips 66
PSX
$82.9B
| $33.7M | 0.07% |
417,060
-1,565,660
| -79% | -$133M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.